MMJ Recs

JULY 11, 2020

An alarmingly high number of deaths in many countries has led to researchers scrambling to find an effective treatment or cure for the disease. One recent study conducted in Canada looked at whether marijuana might be an option for coronavirus treatment. So, could cannabis help treat coronavirus (COVID-19)? How can you get an MMJ card?

Research and Development 52

Research and Development Treatment Clinical Trials Therapy 52

CannaMD

SEPTEMBER 28, 2020

Researchers are taking a new look at an ancient sleep treatment, Cannabis sativa , a plant long used to induce slumber. Scientists have also studied combinations of THC and CBD, such as Sativex clinical trials that show patients’ marked improvement in sleep. However, there is a tradeoff between effectiveness and safety.

Sleep 72

Sleep Clinical Trials Patients THC 72

Cannabis Law Report

MARCH 16, 2022

The PsyBio team has extensive experience in drug discovery and development based on synthetic biology, metabolic engineering, medicinal chemistry and clinical pharmacology, as well as clinical and regulatory expertise progressing drugs through human studies and governmental protocols. About PsyBio Therapeutics Corp.

Research and Development 52

Research and Development Pharmaceutical Clinical Trials Medicine 52

Kind Meds (Cannabis Education Blog)

NOVEMBER 16, 2022

Researchers believe CBN is promising in that it may be beneficial in the treatment of some common ailments. CBN has the potential to treat many other conditions. CBN is believed to relieve symptoms of conditions in which seizures are a symptom, including epilepsy. These receptors play an active part in neurological behaviors.

Sleep 94

Sleep Cannabinoids THC CBD 94

Cannabis Law Report

JANUARY 5, 2022

“This patent issuance is rewarding and timely as we launch our Phase 2 trial of MYMD-1 as a therapy for sarcopenia, frailty, and aging, which is currently recruiting patients,” said Chris Chapman, M.D., President, Director and Chief Medical Officer of MyMD. 2 Goates et al. 3 Koon Yee-Lee et al. Robert Schatz. 646) 421-9523.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. CBG, however, also has some medicinal potential that CBD doesn’t, for instance as a treatment for hypertension and insulin resistance. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JULY 24, 2019

Curaleaf CURLF, -7.27% is “illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases,” the FDA wrote. Mental conditions like anxiety, depression, and PTSD.”.

CBD 51

CBD Tincture Pets Chronic Pain 51

The Cannigma

DECEMBER 12, 2022

And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. Now, psychedelic research is booming. Are psychedelics safe?

History 119

History Microdosing Research and Development Clinical Trials 119

Medical Cannabis Seedbank

FEBRUARY 26, 2018

Unfortunately, many of those victims are either unaware or simply have not been given the option of alternative treatments to the more orthodox chemotherapy. The alternative treatment that we will focus on in this post is the use of medical cannabis and its healing qualities. Countries such as the U.S.A Encourage appetite.

Treatment 63

Treatment Patients Clinical Trials THC 63

TheAnswerPage

JANUARY 11, 2022

Well, if your answer is ‘no,’ you are definitely not alone. For example, most, if not all, states have legalized the use of medical marijuana to treat specific health conditions for which there is no or only poor quality clinical evidence of efficacy and safety. BMC Fam Pract. 2021;22(1):212. Published 2021 Oct 21.

Patients 98

Patients Education Marijuana Therapy 98

SpeedWeed

AUGUST 4, 2021

This event saw doctors and researchers from all over the world presenting the scientific and clinical studies surrounding the medical benefits of cannabis. . They presented case studies about patients who have had incredible success from their cannabis treatments. Where do you see your firm in the next 10 years?

Chronic Pain 52

Chronic Pain Research and Development Medicine Supply Chain 52

Greencamp

FEBRUARY 2, 2019

Examples include pneumonia, cancers, tuberculosis, chronic diarrhea, and inflammation-based conditions such as meningitis and encephalitis. Depending on what type of cell it is, but also the type of condition a person is struggling with, these factors determine the way how will a specific cell react to cannabinoids.

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

SpeedWeed

MARCH 5, 2021

One, they have been determined by the US Food and Drug Administration to be clinically safe and effective treatments for a specific medical condition. Removing cannabis from the CSA, a/k/a descheduling, would not amend its legal definition in such a way that it would meet either requirement.

Business 52

Business Policy Clinical Trials Research and Development 52

CannaMD

AUGUST 8, 2020

Drugs, substances, and certain chemicals used to make drugs are classified into five categories (known as schedules ) depending on the Department of Drug Enforcement Agency (DEA)’s definition of the drug’s acceptable medical use and abuse/dependency potential. What can CBD do? The easier question is: What can’t CBD do?!

CBD 99

CBD DEA Research and Development Hemp 99

Greencamp

AUGUST 16, 2018

The available body of evidence suggests that besides the lessening of symptoms, cannabis is also capable of slowing down the overall rate of progression of this horrible condition. Modern science hasn’t found a cure for this condition so far, and the most frequent cause of death is respiratory failure due to muscle decay.

Strains 94

Strains Cannabinoids Research and Development Indica 94

The Joint Blog

JULY 25, 2020

The agency maintains that they need more time to probe further into the science of cannabidiol, which will require thorough research and clinical trials before they can conclude certain products as GRAS. “To Also, the FDA has concluded that “ THC and CBD products are excluded from the dietary supplement definition.”

CBD 33

CBD Clinical Trials Safety Media 33

Puff Puff Post

NOVEMBER 5, 2019

. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. Most types of epidermolysis bullosa are inherited. About INM-755.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

Cannabis Law Report

JANUARY 20, 2022

Eleusis designed ELE-Psilo, a proprietary psilocybin-based drug candidate that is formulated for IV infusion and in development for the treatment of depression. Eleusis secured an Innovation Passport Designation for ELE-Psilo in adult treatment-resistant depression under the U.K.

Therapy 52

Therapy Research and Development Business Access 52

Cannabis Info

OCTOBER 11, 2019

Cannabis & Dementia: New Study Explores Pot’s Potential for Treatment. In the decades since the medical marijuana movement began in earnest in the 1970s, cannabis has been anecdotally touted as an effective treatment for a variety of illnesses, including those impacting brain function, such as seizures, anxiety and depression.

Treatment 45

Treatment Clinical Trials Cannabinoids Cannabis 45

Veriheal

APRIL 18, 2022

F or example, the study reports a definitive correlation between accelerated aging and lifetime cannabis use. The researchers conducted a study on mice and found that they were “able to regress to the state of two-month-old mice with a prolonged low-dose treatment with a cannabis active ingredient.” . The Final Verdict.

Research and Development 98

Research and Development Clinical Trials Conditions Cannabis 98

Cannabis Law Report

APRIL 13, 2022

Complementary businesses combine to create a preeminent North American platform with operations spanning 13 wellness clinics, four research sites and one bioanalytical laboratory. Hosting clinical trials for MDMA ( MAPS Public Benefit Corporation), psilocybin (the Usona Institute), LSD (MindMed) and ketamine (the University of Utah ).

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Cannabis Law Report

OCTOBER 26, 2019

One such circumstance is a clinical trial. A clinical trial in Australia must have an Australian sponsor (whether it be an individual (e.g., Two of the avenues for supply of UTGs for clinical trials are the Clinical Trial Exemption (CTX) Scheme and the Clinical Trial Notification (CTN) Scheme.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Project CBD

FEBRUARY 28, 2023

Under section 201(ff)(3)(B) of the Federal Food, Drug, and Cosmetic Act — in what some refer to as the “drug preclusion clause” 4 — any substance that is an active ingredient in an approved drug product, or that is being publicly investigated as such, is excluded from the definition of a legal dietary supplement ingredient. 2021.06.005.

CBD 144

CBD Seed-To-Sale Food Access 144

Canna Law Blog

MARCH 4, 2020

From 2015 to 2018, the number of clinics increased from 60 to 300; that number is undoubtedly higher today. People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs. Ketamine is also widely known as a popular party drug (“ Special K “).

Therapy 89

Therapy Legalization Chronic Pain DEA 89

Project CBD

MAY 3, 2023

CannMed: For what conditions do you think CBG has the most promise? Psoriasis is a well-known condition where people get not only joint pain but they also get these thick red patches and scales on their skin. It can be a very difficult condition. But we may be on the cusp of having those trials, which would be very exciting.

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Cannabis Law Report

DECEMBER 20, 2021

Finally the definition of cannabis included ‘ flowering or fruiting tops (excluding seeds and leaves when not accompanied by tops ) from which resin is not extracted ‘ 4. It is imperative to note here that the leaves and the seeds have been excluded from the above definition.

Seed-To-Sale 52

Seed-To-Sale Hemp Food Clinical Trials 52

CannaMD

MARCH 8, 2020

The study touched on a number of both general and specific concerns related to marijuana’s potential role in a range of cardiovascular disorders, but ultimately offered no specific and definitive conclusions. Few randomized clinical trials have been conducted or are planned to explore the effects of marijuana on cardiovascular risk.

Patients 79

Patients Marijuana Research and Development Clinical Trials 79

Canna Law Blog

MARCH 4, 2020

From 2015 to 2018, the number of clinics increased from 60 to 300; that number is undoubtedly higher today. People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs. Ketamine is also widely known as a popular party drug (“ Special K “).

Legalization 52

Legalization Therapy Chronic Pain DEA 52

Puff Puff Post

NOVEMBER 5, 2019

. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. Most types of epidermolysis bullosa are inherited. About INM-755.

Clinical Trials 8

Clinical Trials Pharmaceutical Cannabinoids Data 8

CannaMD

OCTOBER 7, 2019

Besides going against all the classic “munchies/stoner” stereotypes, this finding is especially puzzling as cannabis is often used to increase weight gain in patients with medical conditions such as HIV/AIDS and cancer. So why are medical marijuana patients gaining weight when they need to, but losing weight when they don’t?

Marijuana 105

Marijuana Cannabinoids Patients Conditions 105

The Cannigma

MARCH 12, 2021

However, many customers, new medical cannabis customers are going into the dispensary with a note from their doctor saying you qualify under one of the state conditions that enable you to use cannabis. I think when customers go to a dispensary, they’re assuming it’s going to be the same type of experience. How do you address that?

Legalization 128

Legalization Patients Education Dispensary 128

Cannabis Law Report

DECEMBER 21, 2019

Joseph Billions writes for Cannabis Law Report……So much work has gone into fully determining the medical applications of cannabis, endless works of research have been conducted on how this gift of nature can help make the world a better place and so far there have been numerous breakthroughs among which is autism treatment.

Research and Development 59

Research and Development CBD Conditions Therapy 59

The Cannigma

DECEMBER 22, 2021

EG: Yeah, definitely. At the moment, you said that they could potentially add more conditions. What conditions, or indications can doctors prescribe for in Israel at the moment? IR: Well, today, there is a closed list, basically, of conditions. It’s actually making decisions, what is the definition of the product?

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. Spasticity from neurological conditions. Background. Conclusions.

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

FEBRUARY 11, 2021

There was definitely no way of ensuring that you got the same effect from it consistently. One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. And what about conditions? I know how to collect data. I know how to analyze data.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

The Cannigma

MAY 7, 2021

I think we’re needing to kind of understand how we classify medical cannabis in Europe in order to improve the volume of access for patients across Europe because at the minute, it’s still very restrictive in terms of who can prescribe and what they can prescribe and for what conditions of course, what they can prescribe for.

Supply Chain 120

Supply Chain Patients Access Hemp 120

Cannabis Law Report

OCTOBER 29, 2019

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45

Safety CBD Clinical Trials Oil 45